Moreover, in vivo observations show that in CCL2 (chemokine ligand for CCR2) deficient oral CIS lesions, hBD-3 over-expression acts to selectively recruit tumor-associated macrophages to CIS lesions (44). The gene discussed is CCL2; the disease is in situ carcinoma.